SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS
Jing Bai et al · Frontiers Media S.A · 2026
A combined model of BCVA, TRAb, and NLR predicts response to intravenous methylprednisolone in dysthyroid optic neuropathy
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Resumen
Descripción general del contenido del recurso.
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, J. B. E. (2026). SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS. https://doi.org/10.3389/fmed.2026.1789222
MLA
al, Jing Bai et. "SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS." 2026. https://doi.org/10.3389/fmed.2026.1789222.
Chicago
al, Jing Bai et. 2026. "SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS.". https://doi.org/10.3389/fmed.2026.1789222.
Harvard
al, J. B. E. 2026, SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS, Frontiers Media S.A, available at: https://doi.org/10.3389/fmed.2026.1789222 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- SHP2 in TAMs promoted the survival of gastric adenocarcinoma via suppressing the P38/ERK1/2/SP1/BRD4/STING induced inflammation and ROS
- Autor / colaboradores
- Jing Bai et al
- Editorial
- Frontiers Media S.A
- Año de publicación
- 2026
- ISSN
- 2296-858X
- ISSN
- 2296-858X
- Idioma
- eng
Materias
Explorá otros recursos relacionados a partir de estas materias.